A detailed history of Amalgamated Bank transactions in Vericel Corp stock. As of the latest transaction made, Amalgamated Bank holds 14,385 shares of VCEL stock, worth $826,130. This represents 0.01% of its overall portfolio holdings.

Number of Shares
14,385
Previous 14,649 1.8%
Holding current value
$826,130
Previous $672,000 9.52%
% of portfolio
0.01%
Previous 0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$42.25 - $53.56 $11,154 - $14,139
-264 Reduced 1.8%
14,385 $608,000
Q2 2024

Aug 12, 2024

SELL
$41.71 - $52.9 $11,637 - $14,759
-279 Reduced 1.87%
14,649 $672,000
Q1 2024

Apr 23, 2024

SELL
$32.52 - $52.33 $189,331 - $304,665
-5,822 Reduced 28.06%
14,928 $777,000
Q4 2023

Feb 06, 2024

SELL
$30.85 - $37.09 $10,396 - $12,499
-337 Reduced 1.6%
20,750 $739,000
Q3 2023

Nov 08, 2023

SELL
$31.69 - $39.25 $18,855 - $23,353
-595 Reduced 2.74%
21,087 $707,000
Q2 2023

Aug 11, 2023

BUY
$29.0 - $38.37 $3,857 - $5,103
133 Added 0.62%
21,682 $814,000
Q1 2023

May 02, 2023

SELL
$23.85 - $31.34 $31,171 - $40,961
-1,307 Reduced 5.72%
21,549 $632,000
Q3 2022

Nov 09, 2022

BUY
$22.62 - $32.54 $5,066 - $7,288
224 Added 0.99%
22,856 $530,000
Q2 2022

Aug 15, 2022

SELL
$22.88 - $39.45 $7,115 - $12,268
-311 Reduced 1.36%
22,632 $570,000
Q1 2022

Jun 30, 2022

SELL
$31.69 - $43.29 $39,168 - $53,506
-1,236 Reduced 5.11%
22,943 $877,000
Q4 2021

Feb 15, 2022

SELL
$35.2 - $52.6 $11,792 - $17,621
-335 Reduced 1.37%
24,179 $950,000
Q3 2021

Oct 29, 2021

SELL
$46.35 - $59.75 $10,382 - $13,384
-224 Reduced 0.91%
24,514 $1.2 Million
Q2 2021

Aug 16, 2021

BUY
$47.2 - $67.81 $857,199 - $1.23 Million
18,161 Added 276.13%
24,738 $1.3 Million
Q1 2021

May 13, 2021

SELL
$30.93 - $59.48 $4,701 - $9,040
-152 Reduced 2.26%
6,577 $365,000
Q4 2020

Feb 12, 2021

BUY
$18.53 - $31.5 $124,688 - $211,963
6,729 New
6,729 $207,000

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.71B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.